The problem is they can't just wait, they need more funds. Would be a whole different story if they had 3 years worth of money in the bank, but as it stands they need more cash sooner rather than later. That's why I don't think any of the things you mention will help in the short term, maybe in the the long term.
Exactly. Those who want to sell out now for $20 a share either do not have the patience to invest in biotech or they cannot afford to have patience. Because other than the share price nothing has changed, particularly not the science. With approvable interim data this company could very likely be taken out for KITE money or better. $10b+ easily.
News 
Market Data 
Discover 
